StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 1 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Recs

0
Player Avatar pchop123 (76.62) Submitted: 8/2/2012 4:27:17 PM : Underperform Start Price: $1.83 STEM Score: +10.47

give back time

Featured Broker Partners


Advertisement